In summary, it seems that obese men with a low risk of developing prostate cancer have lower serum PSA levels than their non-obese counterparts; the presence of prostate cancer might attenuate ...
IRVINE, Calif. - Biomerica, Inc. (NASDAQ:BMRA), a diagnostic solutions provider with a market capitalization of $6.4 million and showing a notable 16.6% year-to-date stock return, has received ...
Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.
UAE health ministry approves Biomerica’s Fortel PSA Screening Test to detect an early sign of prostate cancer: Irvine, California Saturday, January 18, 2025, 14:00 Hrs [IST] Bio ...